ArticleFrontiers in nutrition2026
Machine learning based on body composition radiomics for predicting early recurrence in colorectal cancer: a multicenter study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early recurrence (ER) in colorectal cancer (CRC) leads to dismal outcomes. Current pTNM staging fails to capture the host's systemic pathophysiological status. We developed an interpretable machine learning (ML) model based on preoperative CT body composition radiomics to predict ER in CRC. Methods: This multicenter study enrolled 917 patients who underwent radical resection across three independent institutions, and the cohort was partitioned into a training set ( Results: An 11-feature radiomics signature was identified. The Random Forest model demonstrated optimal generalization, yielding AUCs of 0.807, 0.776, and 0.750 in the training and two test sets, respectively. SHAP analysis revealed that IMAT (46.1%) and SM (42.9%) features were primary drivers, and increased SM textural uniformity may reflect adverse muscle quality and possible myosteatosis-related tissue alterations. The individualized radiomics risk score effectively stratified patients, demonstrating significantly divergent recurrence-free and overall survival across all cohorts ( Conclusion: This interpretable ML model may improve ER risk stratification in CRC and provide a quantitative tool for individualized postoperative surveillance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.